SEC Comment Letter 0000000000-26-000439 to AETHLON MEDICAL INC (AEMD)

AETHLON MEDICAL INC
Date: Jan. 13, 2026 · CIK: 0000882291 · Accession: 0000000000-26-000439

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-292598

Date

January 13, 2026

Author

James Frakes

Form

UPLOAD

Company

AETHLON MEDICAL INC

Letter

January 13, 2026 James Frakes Chief Executive Officer Aethlon Medical, Inc. 11555 Sorrento Valley Road Suite 203 San Diego, CA 92121 Re:Aethlon Medical, Inc. Registration Statement on Form S-1 Filed January 7, 2026 File No. 333-292598 Dear James Frakes: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement and non-public draft submission on EDGAR at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Robert Augustin at 202-551-8483 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Dennis Doucette

Show Raw Text

January 13, 2026
James Frakes
Chief Executive Officer
Aethlon Medical, Inc.
11555 Sorrento Valley Road
Suite 203
San Diego, CA 92121
Re:Aethlon Medical, Inc.
Registration Statement on Form S-1
Filed January 7, 2026
File No. 333-292598
Dear James Frakes:
            This is to advise you that we do not intend to review your registration statement.
            We request that you publicly file your registration statement and non-public draft
submission on EDGAR at least two business days prior to the requested effective date and
time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Robert Augustin at 202-551-8483 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:Dennis Doucette

SecProbe.io